Influenza Vaccine (Split Virion), Inactivated, Quadrivalent (Sinovac Biotech)

四价流感病毒裂解疫苗（科兴生物）

Report date: 2026/05/20 20:02:01

Base Information

Drug NameInfluenza Vaccine (Split Virion), Inactivated, Quadrivalent (Sinovac Biotech)
Drug Alias NameInfluenza virus vaccine quadrivalent (Sinovac biotech)科兴四价流感疫苗
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Biological material > Viral vaccineVaccines > Development/production technology > Inactivated vaccine > Split vaccine +[5] 
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsInfluenza, HumanInfluenza B virus infection
Global Approved IndicationsInfluenza, Human
Approved Indications in ChinaInfluenza, Human
Original Approved Country/TerritoryMainland China
Original Approved Date2020/06/17
Country/TerritoryPhilippinesChileMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesSinovac Biotech Ltd
China Registration ClassN/A

Develop Information

Active CompaniesSinovac Biotech (Chile) SPAPontificia Universidad Catolica De ChileSinovac Biotech Co Ltd +[4] 
Inactive CompaniesN/A
Active IndicationsInfluenza, HumanInfluenza B virus infection
Inactive IndicationsN/A

Other Information

ATC CodeJ07BB02
Related LinksN/A